Prof. Stefano Miceli Sopo works out of the
Department of Pediatrics at Catholic University of the Sacred Heart in Rome,
Italy. He has co-authored several studies on Food Protein Induced Enterocolitis
Syndrome including:
- “Clinical management of food protein-induced enterocolitis syndrome”
- "FPIES, From Practice to Theory"
- “Food protein-induced enterocolitis syndrome (FPIES) and well cooked foods: A working hypothesis”
- “Ondansetron for Food Protein-Induced Enterocolitis Syndrome”
- “Chronic Food Protein-Induced Enterocolitis Syndrome Caused by Cow's Milk Proteins Passed through Breast Milk”
Prof. Stefano Miceli
Sopo and his colleagues are passionate about FPIES research and the need for a
Global FPIES Patient Registry. We recently had the opportunity to speak with
Prof. Miceli Sopo who works with a center in Rome that follows and studies
FPIES children.
Prof. Miceli Sopo says the most surprising thing for him is that there is still very little research being done on FPIES. He says even most of the studies that are being done seem to offer only descriptions of case studies and maybe some guidelines. He says, "We read little about the search for new treatments, to better understand its pathogenesis."
Prof. Miceli Sopo says the most surprising thing for him is that there is still very little research being done on FPIES. He says even most of the studies that are being done seem to offer only descriptions of case studies and maybe some guidelines. He says, "We read little about the search for new treatments, to better understand its pathogenesis."
Prof.
Miceli Sopo says one of the most interesting recent aspects of FPIES research
has to do with the promising effects of Ondansetron, during the acute phase of
FPIES. Ondansetron is an anti-vomiting
medication, typically used to help chemotherapy patients. He says in twenty of his case studies Ondansetron
was administered and seemed to work well.
Prof. Miceli Sopo has
made it a goal to create an FPIES registry in Italy and says there is a great
need for a Global Registry, like the FPIES Foundation Global Registry. He says, "It would be a really good
thing" to have a central platform that was functional and affordable to
provide information to pediatric allergy centers around the world. He says a global registry would help doctors
get on the same page when it comes to diagnosing FPIES. Prof. Miceli Sopo says, "I believe there
may be some differences. We believe that
we need a greater unanimity of behaviors.
The registry will serve to highlight the differences; we will try to
eliminate them."
Prof. Miceli Sopo says
hopefully a registry can also shed some light of what appears to be a spectrum
of FPIES patients who suffer from varying degrees of the condition. He says, "Just through the registry maybe
we can see if there is a phenotype that tolerates small amounts of food, maybe
processed in some way, and those who vomit after eating only a few milligrams
of the food culprit."
Research of course
takes time so Prof. Miceli Sopo says until we have more answers patients should
keep an open dialogue with their doctors.
He says if there is any suspicion of FPIES he suggests eliminating the
food, even if the suspicion is weak, and to carry out an Oral Food Challenge
soon as possible. Prof. Miceli Sopo says,
"We have heard stories of children, who had 6-8 acute episodes before
arriving at the diagnosis, it does not seem right."
If you interested in learning more about the Italian FPIES registry
write to stefano.micelisopo@gmail.com
To join the FPIES
Foundation Global Patient Registry follow this link. If you've already joined you can instantly
see survey and data results by clicking “View Data” here.
This interview conducted and article written by Victoria Warren. Victoria is a television news reporter for the NBC affiliate in Boston, WHDH-TV. Victoria is a parent volunteer with The FPIES Foundation Volunteer Advisory Board. Follow Victoria on twitter @VWarrenon7.